Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

GREY:ATTBF - Post by User

Abattis Bioceuticals Corp

Bullboard Posts

Post by fasttrack5on May 01, 2018 2:58am

223 Views

Post# 27962724

ATT

Abattis Completes Acquisition of Remaining Minority Interest in Gabriola Green Farms

April 30, 2018 | Abattis Bioceuticals

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce, further to its news release dated April 18, 2018, that it has completed its acquisition of the remaining 10% ownership interest (the “Interest”) in its subsidiary, Gabriola Green Farms Inc. (“Gabriola”). Abattis acquired the Interest from CannaNUMUS Blockchain Inc. for $2.5 million. Gabriola is now a wholly-owned subsidiary of the Company.

Bullboard Posts

Sirios Resource discovers visible gold in Quebec